AppLovin’s growth story is fading, as the company reported a sequential decline in EPS in the latest quarter despite ...

Quantum Computing hype? Learn why experts predict a 90% stock drop, highlighting red flags like minimal revenue and high ...

Discover why Arbor Realty Trust stands out as a contrarian buy with strong recovery potential, a 12% yield, and robust risk ...

Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY ...

The Fed Chair Powell stated during the press conference following the June meeting that there is "a meaningful inflation ...

Innoviz Technologies Ltd. secured a major OEM deal, leading in Lidar's growth race. Click for why INVZ is a high-risk, ...

Explore Qualys' strong niche in exposure management, robust financials, and conservative strategy amidst rising competition ...

Oscar Health is uniquely undervalued, combining 42% revenue growth with profitability and a low EV/Sales multiple. Click here ...

Sanofi acquires Blueprint Medicines Corporation for $9.1bn, gaining revenue-driving Aykavit and pipeline drug BLU-808 ...

McCoy Global Inc. is set to thrive with automation in tubular running, driving growth and shareholder returns. Click for more ...

Nuvation Bio's FDA approval for IBTROZI isn't boosting its stock. Learn about NUVB's financial risks, valuation concerns, and ...

Yesterday, the NAHB published its latest monthly update on homebuilder sentiment. The headline sentiment index continued to ...